《亞洲股市》日經及港台澳韓股升0.2%-0.5% 惟滬深股市逆軟
美股昨晚於CPI數據前全面先升後跌,美債息率繼續顯著回落,10年期債息降至1.489%,蘋果、Alphabet、亞馬遜、微軟及IBM續升0.3%-1.1%,但「網紅股」大幅波動普遍先急漲後跌,散戶「挾淡倉」新目標的醫療保健科技公司Clover Health承前天飆86%勢,股價曾再漲30%至28.85美元無以為繼,獲利盤湧現,拖累股價倒跌近24%收16.92美元,加上Tesla、fb和奈飛跌0.8%-1.3%,以及費城半導體三連軟,拖累納指由曾續漲近0.6%至14,003,轉跌0.1%收13,911,結束兩連漲;默克生產新冠口服藥物試驗一旦確定有效並獲美國藥監局批准使用,政府將以12億美元購買170萬劑,刺激股價漲逆升逾2%,安進、強生及據報將獲美政府大量購買新冠疫苗的非藍籌輝瑞也依次升逾1%-2%,但逾三分二藍籌受壓,尤其是Nike、家得寶、Travelers、摩通、運通、波音及卡特彼勒跌逾1%-2%,拖累道指由曾回升55點,轉跌152點或0.4%低收34,447,標普也由曾升0.2%,轉跌0.2%。此外,較早收市的富時、意股及DAX跌0.2%-0.4%;但泛歐600、CAC及西班牙反覆微升不足0.2%。
美股期貨全面回升0.1%。亞太區股市早段全面靠穩。美元兌日圓於亞洲偏穩報109.55,日經扭兩連跌,高低見29,007/28,799,現造28,952,反覆回升0.3%。台灣加權指數扭四連跌,報17,044,回升近0.5%。
南韓繼昨天低收續跌1%後,今早回升0.3%報3,226。澳洲200扭昨天破頂倒跌勢,報7,301,回升0.4%。紐西蘭50指數三連升後,今早靠穩,報12,573,升7點。新加坡海峽時報指數扭兩連跌,報3,155,回升2點。吉隆坡綜合指數繼昨天回軟結束兩連升後,今早靠穩報1,582。
港股扭六連跌,今早在創科(00669.HK)高開逾1%及騰訊(00700.HK)、美團(03690.HK)、阿里(09988.HK)略為反彈主導,高開49點或0.2%報28,792。
不過,滬指繼昨天反覆回升0.3%後,今早低開3點或0.1%報3,587;深成繼昨天反覆回穩結束兩連跌後,今早低開3點報14,715。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.